No black box warning on record for Idamycin Pfs

As of the latest FDA labeling reviewed, Idamycin Pfs (IDARUBICIN HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Idamycin Pfs medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Myelosuppression : Severe myelosuppression resulting in severe infection, septic shock, hemorrhage, or death may occur. Obtain complete blood counts prior to each treatment and closely monitor patients during treatment for possible clinical complications due to myelosuppression. (5.4) • Tumor Lysis Syndrome : During treatment, monitor blood chemistries and manage promp

No black box warning on record for Idamycin Pfs

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Myelosuppression : Severe myelosuppression resulting in severe infection, septic shock, hemorrhage, or death may occur. Obtain complete blood counts prior to each treatment and closely monitor patients during treatment for possible clinical complications due to myelosuppression. (5.4) • Tumor Lysis Syndrome : During treatment, monitor blood chemistries and manage promp

Idamycin Pfs Black Box Warning

No black box warning on record for Idamycin Pfs

Other warnings & precautions

Idamycin Pfs Black Box Warning

No black box warning on record for Idamycin Pfs

Other warnings & precautions